Last 12 months
Inside the activity.
5 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 4 | 0 |
| Mar 2026 | 1 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 10, 2023 Filed Feb 14, 2023 21:24 UTC |
Dasu Badri NChief Engineering Officer
|
GrantStock Option (Right to Buy) · Derivative | 29,250 | $0.00 Strike: $1.76 | $0.00 |
DisclosureSEC source: 0001209191-23-009127 · doc4.xml · derivative · entry 3 Dasu Badri N · CIK 0001310803 · Chief Engineering Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,250 Underlying: Common Stock · 29,250 shares Expires 2033-02-09 F4 · derivative.exercise_date: On February 10, 2023, the reporting person was granted an option to purchase 29,250 shares of common stock. One fourth (1/4th) of the option shares shall vest on the one year anniversary of the grant date, and the remaining balance of the option shares shall vest in 36 equal consecutive monthly installments thereafter until fully vested so long as the reporting person remains in continuous service through such applicable vesting periods. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:24 UTC |
Dasu Badri NChief Engineering Officer
|
GrantCommon Stock | 4,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009127 · doc4.xml · nonDerivative · entry 1 Dasu Badri N · CIK 0001310803 · Chief Engineering Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,945 F1 · shares: The restricted stock units shall vest in three equal consecutive annual installments on February 10, 2024, February 10, 2025 and February 10, 2026. F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:22 UTC |
ASADORIAN RAFFIChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 35,250 | $0.00 Strike: $1.76 | $0.00 |
DisclosureSEC source: 0001209191-23-009123 · doc4.xml · derivative · entry 3 ASADORIAN RAFFI · CIK 0001628970 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,250 Underlying: Common Stock · 35,250 shares Expires 2033-02-09 F4 · derivative.exercise_date: On February 10, 2023, the reporting person was granted an option to purchase 35,250 shares of common stock. One fourth (1/4th) of the option shares shall vest on the one year anniversary of the grant date, and the remaining balance of the option shares shall vest in 36 equal consecutive monthly installments thereafter until fully vested so long as the reporting person remains in continuous service through such applicable vesting periods. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:22 UTC |
ASADORIAN RAFFIChief Financial Officer
|
GrantCommon Stock | 5,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009123 · doc4.xml · nonDerivative · entry 1 ASADORIAN RAFFI · CIK 0001628970 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,464 F1 · shares: The restricted stock units shall vest in three equal consecutive annual installments on February 10, 2024, February 10, 2025 and February 10, 2026. F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:19 UTC |
Angotti Vincent J.Director · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 117,000 | $0.00 Strike: $1.76 | $0.00 |
DisclosureSEC source: 0001209191-23-009115 · doc4.xml · derivative · entry 3 Angotti Vincent J. · CIK 0001700225 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,000 Underlying: Common Stock · 117,000 shares Expires 2033-02-09 F4 · derivative.exercise_date: On February 10, 2023, the reporting person was granted an option to purchase 117,000 shares of common stock. One fourth (1/4th) of the option shares shall vest on the one year anniversary of the grant date, and the remaining balance of the option shares shall vest in 36 equal consecutive monthly installments thereafter until fully vested so long as the reporting person remains in continuous service through such applicable vesting periods. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:19 UTC |
Angotti Vincent J.Director · Chief Executive Officer
|
GrantCommon Stock | 19,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009115 · doc4.xml · nonDerivative · entry 1 Angotti Vincent J. · CIK 0001700225 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,860 F1 · shares: The restricted stock units shall vest in three equal consecutive annual installments on February 10, 2024, February 10, 2025 and February 10, 2026. F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| February 06, 2023 Filed Feb 8, 2023 21:51 UTC |
Dasu Badri NChief Engineering Officer
|
Tax withholdingCommon Stock | 458 | $2.02 | $925.16 |
DisclosureSEC source: 0001209191-23-007818 · doc4.xml · nonDerivative · entry 1 Dasu Badri N · CIK 0001310803 · Chief Engineering Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,070 F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. F3 · balance_after: Balance includes non-reportable acquisition of 500 shares of Common Stock through the Company's Employee Stock Purchase Plan. F4 · balance_after: Reflects a 1-for-20 reverse stock split which became effective on October 25, 2022. Read SEC document |
| February 06, 2023 Filed Feb 8, 2023 21:48 UTC |
ASADORIAN RAFFIChief Financial Officer
|
Tax withholdingCommon Stock | 617 | $2.02 | $1,246.34 |
DisclosureSEC source: 0001209191-23-007817 · doc4.xml · nonDerivative · entry 1 ASADORIAN RAFFI · CIK 0001628970 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,589 F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. F3 · balance_after: Reflects a 1-20 reverse stock split which became effective on October 25, 2022. Read SEC document |
| February 06, 2023 Filed Feb 8, 2023 21:46 UTC |
Palmer Pamela PDirector · Chief Medical Officer
|
Tax withholdingCommon Stock | 681 | $2.02 | $1,375.62 |
DisclosureSEC source: 0001209191-23-007816 · doc4.xml · nonDerivative · entry 1 Palmer Pamela P · CIK 0001511365 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,777 F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. F3 · balance_after: Balance includes non-reportable acquisition of 500 shares of Common Stock through the Company's Employee Stock Purchase Plan. F4 · balance_after: Reflects a 1-20 reverse stock split which became effective on October 25, 2022. Read SEC document |
| February 06, 2023 Filed Feb 8, 2023 21:42 UTC |
Angotti Vincent J.Director · Chief Executive Officer
|
Tax withholdingCommon Stock | 1,982 | $2.02 | $4,003.64 |
DisclosureSEC source: 0001209191-23-007814 · doc4.xml · nonDerivative · entry 1 Angotti Vincent J. · CIK 0001700225 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,360 F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. F3 · balance_after: Balance includes non-reportable acquisition of 500 shares of Common Stock through the Company's Employee Stock Purchase Plan. F4 · balance_after: Reflects a 1-20 reverse stock split which became effective on October 25, 2022. Read SEC document |
| July 15, 2022 Filed Jul 15, 2022 23:33 UTC |
Bozilenko MarinaDirector
|
GrantStock Option (Right to Buy) · Derivative | 31,000 | $0.00 Strike: $0.23 | $0.00 |
DisclosureSEC source: 0001209191-22-042310 · doc4.xml · derivative · entry 2 Bozilenko Marina · CIK 0001853794 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,000 Underlying: Common Stock · 31,000 shares Expires 2032-07-14 F3 · derivative.exercise_date: 100% of the option shares subject to the option shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company. Read SEC document |
| July 15, 2022 Filed Jul 15, 2022 23:33 UTC |
Bozilenko MarinaDirector
|
GrantCommon Stock | 15,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-042310 · doc4.xml · nonDerivative · entry 1 Bozilenko Marina · CIK 0001853794 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,500 F1 · security: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company. Read SEC document |
| July 15, 2022 Filed Jul 15, 2022 23:35 UTC |
Broadfoot Jill MarieDirector
|
GrantStock Option (Right to Buy) · Derivative | 31,000 | $0.00 Strike: $0.23 | $0.00 |
DisclosureSEC source: 0001209191-22-042311 · doc4.xml · derivative · entry 2 Broadfoot Jill Marie · CIK 0001305178 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,000 Underlying: Common Stock · 31,000 shares Expires 2032-07-14 F3 · derivative.exercise_date: 100% of the option shares subject to the option shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company. Read SEC document |
| July 15, 2022 Filed Jul 15, 2022 23:35 UTC |
Broadfoot Jill MarieDirector
|
GrantCommon Stock | 15,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-042311 · doc4.xml · nonDerivative · entry 1 Broadfoot Jill Marie · CIK 0001305178 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,500 F1 · security: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company. Read SEC document |
| July 15, 2022 Filed Jul 15, 2022 23:32 UTC |
Afable RichardDirector
|
GrantStock Option (Right to Buy) · Derivative | 31,000 | $0.00 Strike: $0.23 | $0.00 |
DisclosureSEC source: 0001209191-22-042309 · doc4.xml · derivative · entry 2 Afable Richard · CIK 0001594021 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,000 Underlying: Common Stock · 31,000 shares Expires 2032-07-14 F3 · derivative.exercise_date: 100% of the option shares subject to the option shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company. Read SEC document |
| July 15, 2022 Filed Jul 15, 2022 23:32 UTC |
Afable RichardDirector
|
GrantCommon Stock | 15,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-042309 · doc4.xml · nonDerivative · entry 1 Afable Richard · CIK 0001594021 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,750 F1 · security: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company. Read SEC document |
| July 15, 2022 Filed Jul 15, 2022 23:29 UTC |
HOFFMAN STEPHEN JDirector
|
GrantStock Option (Right to Buy) · Derivative | 31,000 | $0.00 Strike: $0.23 | $0.00 |
DisclosureSEC source: 0001209191-22-042307 · doc4.xml · derivative · entry 2 HOFFMAN STEPHEN J · CIK 0001190418 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,000 Underlying: Common Stock · 31,000 shares Expires 2032-07-14 F3 · derivative.exercise_date: 100% of the option shares subject to the option shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company. Read SEC document |
| July 15, 2022 Filed Jul 15, 2022 23:29 UTC |
HOFFMAN STEPHEN JDirector
|
GrantCommon Stock | 15,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-042307 · doc4.xml · nonDerivative · entry 1 HOFFMAN STEPHEN J · CIK 0001190418 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,750 F1 · security: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company. Read SEC document |
| July 15, 2022 Filed Jul 15, 2022 23:31 UTC |
ADAMS ADRIANDirector
|
GrantStock Option (Right to Buy) · Derivative | 31,000 | $0.00 Strike: $0.23 | $0.00 |
DisclosureSEC source: 0001209191-22-042308 · doc4.xml · derivative · entry 2 ADAMS ADRIAN · CIK 0001248144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,000 Underlying: Common Stock · 31,000 shares Expires 2032-07-14 F3 · derivative.exercise_date: 100% of the option shares subject to the option shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company. Read SEC document |
| July 15, 2022 Filed Jul 15, 2022 23:31 UTC |
ADAMS ADRIANDirector
|
GrantCommon Stock | 15,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-042308 · doc4.xml · nonDerivative · entry 1 ADAMS ADRIAN · CIK 0001248144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 211,750 F1 · security: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company. Read SEC document |
| July 15, 2022 Filed Jul 15, 2022 23:27 UTC |
Rosen Howard BDirector
|
GrantStock Option (Right to Buy) · Derivative | 31,000 | $0.00 Strike: $0.23 | $0.00 |
DisclosureSEC source: 0001209191-22-042306 · doc4.xml · derivative · entry 2 Rosen Howard B · CIK 0001307068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,000 Underlying: Common Stock · 31,000 shares Expires 2032-07-14 F3 · derivative.exercise_date: 100% of the option shares subject to the option shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company. Read SEC document |
| July 15, 2022 Filed Jul 15, 2022 23:27 UTC |
Rosen Howard BDirector
|
GrantCommon Stock | 15,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-042306 · doc4.xml · nonDerivative · entry 1 Rosen Howard B · CIK 0001307068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,250 F1 · security: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company. Read SEC document |
| July 15, 2022 Filed Jul 15, 2022 23:26 UTC |
WAN MARK ADirector
|
GrantStock Option (Right to Buy) · Derivative | 31,000 | $0.00 Strike: $0.23 | $0.00 |
DisclosureSEC source: 0001209191-22-042305 · doc4.xml · derivative · entry 2 WAN MARK A · CIK 0001190472 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,000 Underlying: Common Stock · 31,000 shares Expires 2032-07-14 F3 · derivative.exercise_date: 100% of the option shares subject to the option shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company. Read SEC document |
| July 15, 2022 Filed Jul 15, 2022 23:26 UTC |
WAN MARK ADirector
|
GrantCommon Stock | 15,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-042305 · doc4.xml · nonDerivative · entry 1 WAN MARK A · CIK 0001190472 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,750 F1 · security: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company. Read SEC document |
| June 07, 2022 Filed Jun 8, 2022 20:06 UTC |
Angotti Vincent J.Director · Chief Executive Officer
|
PurchaseCommon Stock | 46,400 | $0.22 | $10,333.28 |
DisclosureSEC source: 0001209191-22-035010 · doc4.xml · nonDerivative · entry 1 Angotti Vincent J. · CIK 0001700225 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,016,919 F1 · price: The price reported on Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $0.2187 to $0.2241 on June 7, 2022. The reporting person will provide upon request to the SEC, the issuer or security holder of Issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| March 03, 2022 Filed Mar 4, 2022 21:25 UTC |
Dasu Badri NChief Engineering Officer
|
Tax withholdingCommon Stock | 5,612 | $0.41 | $2,282.96 |
DisclosureSEC source: 0001209191-22-016248 · doc4.xml · nonDerivative · entry 1 Dasu Badri N · CIK 0001310803 · Chief Engineering Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,595 F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. F3 · balance_after: Balance includes non-reportable acquisition of 10,000 shares of Common Stock through the Company's Employee Stock Purchase Plan. Read SEC document |
| March 03, 2022 Filed Mar 4, 2022 21:24 UTC |
Angotti Vincent J.Director · Chief Executive Officer
|
Tax withholdingCommon Stock | 23,051 | $0.41 | $9,377.15 |
DisclosureSEC source: 0001209191-22-016238 · doc4.xml · nonDerivative · entry 1 Angotti Vincent J. · CIK 0001700225 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 970,519 F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. F3 · balance_after: Balance includes non-reportable acquisition of 10,000 shares of Common Stock through the Company's Employee Stock Purchase Plan. Read SEC document |
| March 03, 2022 Filed Mar 4, 2022 21:26 UTC |
Palmer Pamela PDirector · Chief Medical Officer
|
Tax withholdingCommon Stock | 7,923 | $0.41 | $3,223.08 |
DisclosureSEC source: 0001209191-22-016251 · doc4.xml · nonDerivative · entry 1 Palmer Pamela P · CIK 0001511365 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 779,261 F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. F3 · balance_after: Balance includes non-reportable acquisition of 10,000 shares of Common Stock through the Company's Employee Stock Purchase Plan. Read SEC document |
| March 03, 2022 Filed Mar 4, 2022 21:25 UTC |
ASADORIAN RAFFIChief Financial Officer
|
Tax withholdingCommon Stock | 7,923 | $0.41 | $3,223.08 |
DisclosureSEC source: 0001209191-22-016242 · doc4.xml · nonDerivative · entry 1 ASADORIAN RAFFI · CIK 0001628970 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 364,205 F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. F3 · balance_after: Balance includes non-reportable acquisition of 4,040 shares of Common Stock through the Company's Employee Stock Purchase Plan. F4 · balance_after: On February 14, 2022, the reporting person filed a Form 4 which inadvertently under-reported his holdings in the Issuer by 8 shares. In addition to reporting the current transactions, this Form 4 serves to correct the reporting person's holdings in the Issuer. Read SEC document |
| February 11, 2022 Filed Feb 14, 2022 21:52 UTC |
Palmer Pamela PDirector · Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 245,000 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001209191-22-009353 · doc4.xml · derivative · entry 3 Palmer Pamela P · CIK 0001511365 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,000 Underlying: Common Stock · 245,000 shares Expires 2032-02-11 F4 · derivative.exercise_date: On February 11, 2022, the reporting person was granted an option to purchase 245,000 shares of common stock. One fourth (1/4th) of the option shares shall vest on the one year anniversary of the grant date, and the remaining balance of the option shares shall vest in 36 equal consecutive monthly installments thereafter until fully vested so long as the reporting person remains in continuous service through such applicable vesting periods. Read SEC document |
| February 11, 2022 Filed Feb 14, 2022 21:52 UTC |
Palmer Pamela PDirector · Chief Medical Officer
|
Tax withholdingCommon Stock | 7,927 | $0.40 | $3,181.90 |
DisclosureSEC source: 0001209191-22-009353 · doc4.xml · nonDerivative · entry 2 Palmer Pamela P · CIK 0001511365 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 777,184 F3 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. Read SEC document |
| February 11, 2022 Filed Feb 14, 2022 21:52 UTC |
Palmer Pamela PDirector · Chief Medical Officer
|
GrantCommon Stock | 122,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-009353 · doc4.xml · nonDerivative · entry 1 Palmer Pamela P · CIK 0001511365 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 785,111 F1 · shares: The restricted stock units shall vest in three equal consecutive annual installments on February 11, 2023, February 11, 2024 and February 11, 2025. F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| February 11, 2022 Filed Feb 14, 2022 21:51 UTC |
Dasu Badri NChief Engineering Officer
|
GrantStock Option (Right to Buy) · Derivative | 195,000 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001209191-22-009349 · doc4.xml · derivative · entry 3 Dasu Badri N · CIK 0001310803 · Chief Engineering Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,000 Underlying: Common Stock · 195,000 shares Expires 2032-02-11 F4 · derivative.exercise_date: On February 11, 2022, the reporting person was granted an option to purchase 195,000 shares of common stock. One fourth (1/4th) of the option shares shall vest on the one year anniversary of the grant date, and the remaining balance of the option shares shall vest in 36 equal consecutive monthly installments thereafter until fully vested so long as the reporting person remains in continuous service through such applicable vesting periods. Read SEC document |
| February 11, 2022 Filed Feb 14, 2022 21:51 UTC |
Dasu Badri NChief Engineering Officer
|
Tax withholdingCommon Stock | 5,615 | $0.40 | $2,253.86 |
DisclosureSEC source: 0001209191-22-009349 · doc4.xml · nonDerivative · entry 2 Dasu Badri N · CIK 0001310803 · Chief Engineering Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 296,207 F3 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. Read SEC document |
| February 11, 2022 Filed Feb 14, 2022 21:51 UTC |
Dasu Badri NChief Engineering Officer
|
GrantCommon Stock | 97,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-009349 · doc4.xml · nonDerivative · entry 1 Dasu Badri N · CIK 0001310803 · Chief Engineering Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 301,822 F1 · shares: The restricted stock units shall vest in three equal consecutive annual installments on February 11, 2023, February 11, 2024 and February 11, 2025. F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| February 11, 2022 Filed Feb 14, 2022 21:50 UTC |
ASADORIAN RAFFIChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 235,000 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001209191-22-009346 · doc4.xml · derivative · entry 3 ASADORIAN RAFFI · CIK 0001628970 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,000 Underlying: Common Stock · 235,000 shares Expires 2032-02-11 F4 · derivative.exercise_date: On February 11, 2022, the reporting person was granted an option to purchase 235,000 shares of common stock. One fourth (1/4th) of the option shares shall vest on the one year anniversary of the grant date, and the remaining balance of the option shares shall vest in 36 equal consecutive monthly installments thereafter until fully vested so long as the reporting person remains in continuous service through such applicable vesting periods. Read SEC document |
| February 11, 2022 Filed Feb 14, 2022 21:50 UTC |
ASADORIAN RAFFIChief Financial Officer
|
Tax withholdingCommon Stock | 7,927 | $0.40 | $3,181.90 |
DisclosureSEC source: 0001209191-22-009346 · doc4.xml · nonDerivative · entry 2 ASADORIAN RAFFI · CIK 0001628970 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 368,080 F3 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. Read SEC document |
| February 11, 2022 Filed Feb 14, 2022 21:50 UTC |
ASADORIAN RAFFIChief Financial Officer
|
GrantCommon Stock | 117,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-009346 · doc4.xml · nonDerivative · entry 1 ASADORIAN RAFFI · CIK 0001628970 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 376,015 F1 · shares: The restricted stock units shall vest in three equal consecutive annual installments on February 11, 2023, February 11, 2024 and February 11, 2025. F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| February 11, 2022 Filed Feb 14, 2022 21:49 UTC |
Angotti Vincent J.Director · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 780,000 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001209191-22-009343 · doc4.xml · derivative · entry 3 Angotti Vincent J. · CIK 0001700225 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 780,000 Underlying: Common Stock · 780,000 shares Expires 2032-02-11 F4 · derivative.exercise_date: On February 11, 2022, the reporting person was granted an option to purchase 780,000 shares of common stock. One fourth (1/4th) of the option shares shall vest on the one year anniversary of the grant date, and the remaining balance of the option shares shall vest in 36 equal consecutive monthly installments thereafter until fully vested so long as the reporting person remains in continuous service through such applicable vesting periods. Read SEC document |
| February 11, 2022 Filed Feb 14, 2022 21:49 UTC |
Angotti Vincent J.Director · Chief Executive Officer
|
Tax withholdingCommon Stock | 23,058 | $0.40 | $9,255.48 |
DisclosureSEC source: 0001209191-22-009343 · doc4.xml · nonDerivative · entry 2 Angotti Vincent J. · CIK 0001700225 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 983,570 F3 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. Read SEC document |
| February 11, 2022 Filed Feb 14, 2022 21:49 UTC |
Angotti Vincent J.Director · Chief Executive Officer
|
GrantCommon Stock | 390,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-009343 · doc4.xml · nonDerivative · entry 1 Angotti Vincent J. · CIK 0001700225 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,006,628 F1 · shares: The restricted stock units shall vest in three equal consecutive annual installments on February 11, 2023, February 11, 2024 and February 11, 2025. F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Read SEC document |
| February 06, 2022 Filed Feb 8, 2022 01:20 UTC |
Palmer Pamela PDirector · Chief Medical Officer
|
Tax withholdingCommon Stock | 9,391 | $0.43 | $4,049.40 |
DisclosureSEC source: 0001209191-22-007635 · doc4.xml · nonDerivative · entry 1 Palmer Pamela P · CIK 0001511365 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 662,611 F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. F3 · balance_after: Balance includes non-reportable acquisition of 5,381 shares of Common Stock through the Company's Employee Stock Purchase Plan. Read SEC document |
| February 06, 2022 Filed Feb 8, 2022 01:19 UTC |
Dasu Badri NChief Engineering Officer
|
Tax withholdingCommon Stock | 6,830 | $0.43 | $2,945.10 |
DisclosureSEC source: 0001209191-22-007634 · doc4.xml · nonDerivative · entry 1 Dasu Badri N · CIK 0001310803 · Chief Engineering Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,322 F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. F3 · balance_after: Balance includes non-reportable acquisition of 6,395 shares of Common Stock through the Company's Employee Stock Purchase Plan. Read SEC document |
| February 06, 2022 Filed Feb 8, 2022 00:58 UTC |
ASADORIAN RAFFIChief Financial Officer
|
Tax withholdingCommon Stock | 9,391 | $0.43 | $4,049.40 |
DisclosureSEC source: 0001209191-22-007623 · doc4.xml · nonDerivative · entry 1 ASADORIAN RAFFI · CIK 0001628970 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258,515 F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. F3 · balance_after: Balance includes non-reportable acquisition of 7,309 shares of Common Stock through the Company's Employee Stock Purchase Plan. Read SEC document |
| February 06, 2022 Filed Feb 8, 2022 00:57 UTC |
Angotti Vincent J.Director · Chief Executive Officer
|
Tax withholdingCommon Stock | 27,318 | $0.43 | $11,779.52 |
DisclosureSEC source: 0001209191-22-007622 · doc4.xml · nonDerivative · entry 1 Angotti Vincent J. · CIK 0001700225 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 616,628 F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs. F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. F3 · balance_after: Balance includes non-reportable acquisition of 6,966 shares of Common Stock through the Company's Employee Stock Purchase Plan. Read SEC document |
| November 20, 2021 Filed Nov 23, 2021 22:37 UTC |
Broadfoot Jill MarieDirector
|
GrantStock Option (Right to Receive) · Derivative | 30,000 | $0.00 Strike: $0.72 | $0.00 |
DisclosureSEC source: 0001209191-21-066559 · doc4.xml · derivative · entry 2 Broadfoot Jill Marie · CIK 0001305178 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2031-11-19 F3 · derivative.exercise_date: The shares subject to the option vest as follows: 1/3rd of the shares subject to the option vest on the one-year anniversary of the date of grant and the remaining shares subject to the option vest on an equal monthly basis over the following 24 months. Read SEC document |
| November 20, 2021 Filed Nov 23, 2021 22:37 UTC |
Broadfoot Jill MarieDirector
|
GrantCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-066559 · doc4.xml · nonDerivative · entry 1 Broadfoot Jill Marie · CIK 0001305178 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 F1 · security: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: The restricted stock units shall vest in three equal consecutive annual installments on November 20, 2022, November 20, 2023 and November 20, 2024. Read SEC document |
| June 17, 2021 Filed Jun 17, 2021 21:27 UTC |
Bozilenko MarinaDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001209191-21-041567 · doc4.xml · derivative · entry 2 Bozilenko Marina · CIK 0001853794 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-06-16 F3 · derivative.exercise_date: 100% of the option shares subject to the option shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company. Read SEC document |
| June 17, 2021 Filed Jun 17, 2021 21:27 UTC |
Bozilenko MarinaDirector
|
GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-041567 · doc4.xml · nonDerivative · entry 1 Bozilenko Marina · CIK 0001853794 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 F1 · security: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · shares: 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company. Read SEC document |
| June 17, 2021 Filed Jun 17, 2021 21:32 UTC |
ADAMS ADRIANDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001209191-21-041579 · doc4.xml · derivative · entry 2 ADAMS ADRIAN · CIK 0001248144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-06-16 F3 · derivative.exercise_date: 100% of the option shares subject to the option shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.